Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Top 5 Top of the line Books of the Year - 2Polar bears are rewiring their own genetics to survive a warming climate
- 3Italy Brings In New Measures In 2026 To Tackle Overtourism
- 4Virtual National Science Foundation internships aren’t just a pandemic stopgap – they can open up opportunities for more STEM students
- 5Eight wounded, cars catch fire in central Israel following strike from Iranian cluster munition
- Employers and staff feel effect of fuel price rise
- 6 Financial plan 3D Printers with the Best Worth
- Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- Baidu robotaxi outage in Wuhan caused by 'system failure', police say
- This widow influencer is using jokes to cope after her husband's death. It's OK if people don't get it.
- The Craft of Computerized Detox: Individual Trials
- Working out at the airport? Some fliers can already smell the sweat.
- Surveys of Music Collections by Film Stars
- Step by step instructions to Appropriately Keep up with Your Sunlight powered chargers for Most extreme Productivity
